Progressive Group
Taipei, Taiwan
Progressive Group is a leading medical distribution company dedicated to providing high-quality medical and diagnostic devices to healthcare providers in Taiwan. As a fully owned subsidiary of Progressive Capital, Progressive Group leverages a robust network and extensive experience in the healthcare industry to ensure that innovative medical solutions are accessible to those who need them. Our expertise in product registration, regulatory compliance, and market distribution enables us to deliver reliable and effective healthcare products. By collaborating with leading manufacturers and having a dedicated sales team operating in every major hospital in Taiwan, we ensure direct access to our advanced medical solutions, thereby enhancing patient care and outcomes.
Primus Medical Shanghai
Shanghai, China
Primus is a leading medical distribution company in China and a fully owned subsidiary of Progressive Capital. Founded in 2005, Primus began with a focus on diagnostic devices and has since expanded its portfolio to include a wide range of innovative medical solutions through partnerships with various companies. The company operates direct sales in major hospitals and collaborates with numerous partners to manage sales channels effectively. Supported by over 100 sales professionals and engineers, Primus serves healthcare professionals across China, enhancing patient care and outcomes. With offices in Beijing, Shanghai, and Guangzhou, and a network of over 200 national distributors, Primus provides comprehensive coverage and support throughout all 31 provinces, autonomous regions, and municipalities.
Senxu Medical
Shanghai, China
Senxu Medical is a leading provider of advanced laboratory management solutions, specializing in patient-based real-time quality control (PBRTQC) systems. Their innovative AI-MA platform leverages deep machine learning algorithms to optimize and monitor quality control in clinical laboratories, ensuring consistency and reliability across multiple analyzers. Senxu Medical offers a range of AI-driven products designed to enhance diagnostic laboratory outcomes, improve the accuracy of test results, and boost laboratory efficiency. These solutions meet the highest standards in clinical diagnostics, supporting healthcare providers in delivering precise and timely patient care. Progressive Group and Primus Medical Shanghai are committed to ensuring that Senxu's advanced products are implemented in diagnostic labs across all hospitals, providing essential support to clinicians and enhancing diagnostic capabilities.
InfraScan Inc.
Philadelphia, USA
InfraScan is a pioneering medical device company specializing in handheld diagnostic tools for detecting intracranial bleeding. Their flagship product, the Infrascanner, uses near-infrared (NIR) technology to identify hematomas, enabling rapid assessment and treatment in emergency settings. This technology is crucial in trauma cases, where swift detection of brain injuries can significantly improve patient outcomes. An entrepreneurial team formed InfraScan around this technology in collaboration with Drexel University. Progressive Capital joined their effort in this lifesaving medical technology in 2017. Both Progressive Group and Primus have collaborated with InfraScan to conduct studies in Taiwanese and Chinese hospitals. InfraScan's products will be sold and distributed by Primus in China. The goal is to help TBI patients triage in the ER and identify intracranial hematomas, a treatable cause of secondary brain injury when detected early.
BandGrip
Chicago, USA
BandGrip is a medical device company focused on developing innovative wound closure solutions. Their flagship product, the BandGrip Micro-Anchor Skin Closure, is designed to simplify and improve wound closure procedures, offering a faster, easier, and less invasive alternative to traditional sutures and staples. BandGrip's technology utilizes micro-anchors to securely close wounds, promoting quicker healing and reducing scarring.Progressive Group has a renowned team covering the wound care market, including expertise in KCI/3M/Solventum negative wound care therapy. By investing in BandGrip, Progressive Capital aims to provide this advanced technology to our subsidiary distributors to better heal patients.
Life Fusion
Tainan, Taiwan
Life Fusion is a medical technology company focused on innovative healthcare solutions. Specializing in patient-focused infusion care solutions, Life Fusion aims to improve the delivery and management of infusion therapies. Their core technology involves high-purity medical-grade collagen extraction. With a dedicated team of experts possessing years of experience in collagen product development, Life Fusion operates a manufacturing facility in the Tainan Science Industrial Park. This strategic location leverages excellent infrastructure and the technological research capabilities of nearby universities to enhance the development of advanced collagen-based beauty technologies.
Aviva Systems Biology
San Diego, USA
Aviva Systems Biology is a leading provider of high-quality antibodies and immunoassay kits. Founded in 2002 with Progressive Group as one of the co-founders, Aviva supports scientists in their basic research, preclinical, drug development, and diagnostics workflows. With a portfolio of nearly 500,000 products for antibodies, proteins, and immunoassays, and over 20 years of expertise in antibody and protein production, scientists can find the unique reagents and support they need for success in their work.
Shanghai, China
GenWay Biotech, Inc.
San Diego, USA
GenWay Biotech is a leading provider of production and manufacturing services for the life sciences and diagnostic industries. Acquired by Aviva Systems Biology in 2017, GenWay maintains ISO13485 accreditation, ensuring high standards in developing, validating, and producing antibodies and proteins for FDA-regulated or CE-marked products. GenWay offers Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) services for research, diagnostic, and government institutions. By integrating GenWay’s capabilities, Aviva Systems Biology delivers advanced product development, large-scale antibody and protein production, ELISA development, and GMP-compliant manufacturing. This synergy positions GenWay as a leader in supporting research and diagnostic needs with high-quality solutions.
Aviva Biosciences
San Diego, USA
Aviva Biosciences was co-founded in 2002 by Progressive Group, with funds from many investors including the China Development Industrial Bank of Taiwan. Aviva Biosciences focuses on developing innovative technologies and solutions to advance biomedical research and diagnostics. Emphasizing cellular and molecular biology, Aviva Biosciences creates cutting-edge tools and platforms designed to enhance the understanding of complex biological systems and improve diagnostic accuracy. Among its impactful products are the Sealchip and the Redsift Cell Processor. These platforms have significantly advanced the quantification of ion channel function and cell screening, which are essential for developing many important drugs. In 2020, Aviva Biosciences was merged with Aviva Systems Biology, further consolidating its innovative assets and expertise within the Aviva brand.
Shanghai United Cell Biotechnology Co. Ltd.
Shanghai, China
Shanghai United Cell Biotechnology Co. Ltd. specializes in the research, development, and commercialization of innovative biotechnology products. Progressive Capital was among the first investors in this company, partnering with Unilab to support its growth and development. The company focuses on creating advanced therapeutic solutions for various medical conditions, including osteoporosis, cholera, traveler's diarrhea, and growth issues in children. United Cell Biotechnology is dedicated to improving patient outcomes and advancing the field of biotechnology. By partnering with leading research institutions and healthcare providers, they strive to bring effective and innovative biotechnology products to the global market, contributing significantly to the progress of medical science and healthcare. Progressive Capital exited their investment in 2015, marking a very successful venture.
Transwell Biotech
Hsinchu, Taiwan
Transwell specializes in developing regenerative cell therapy products, including cells, culture media, and exosome products. Operating from their state-of-the-art manufacturing facility in Hsinchu, Taiwan, Transwell adheres to the highest industry standards, ensuring the reliability and performance of their products. By leveraging their expertise and commitment to quality, Transwell has become a trusted partner for laboratories around the world, driving progress in biotechnology research and applications.
LiLus
Taipei, Taiwan
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.
